We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Multiplex Assay Identifies Diarrheagenic Escherichia coli

By LabMedica International staff writers
Posted on 14 Aug 2014
Print article
Bio-Rad\'s CFX 96 Touch Real-Time PCR System
The CFX 96 Touch Real-Time PCR System (Photo courtesy of BIO-RAD LABORATORIES)
A rapid, reliable and repeatable method is urgently needed for identifying diarrheagenic Escherichia coli (DEC) so as to provide the reference for responding to diarrheal disease outbreaks and the treatment of the diarrheal patients associated with DEC.

A multiplex real-time polymerase chain reaction (PCR) assay based multicolor-combinational probe coding (MCPC) for the identification of eight foodborne pathogens has been developed and applied to the rapid diagnosis of a foodborne disease outbreak successfully.

Molecular biologists at the Xiamen University (China) designed specific primers and modified molecular beacon probes of nine specific virulence genes, whose 5′ end were added with homo tail sequence. They developed and optimized a two-tube modified molecular beacon based multiplex real-time PCR (rtPCR) assay for the identification of five Escherichia coli pathotypes.

A total of 102 bacterial strains, including 52 reference bacterial strains and 50 clinical strains, were isolated to confirm whether the target genes selected were specific. The detection limits of the assay were then tested. Lastly, the assay was applied to the detection of 11,860 clinical samples to evaluate the specificity and sensitivity of the developed assay compared with the conventional PCR. Multiplex rtPCR reactions were performed on the Bio-Rad CFX 96 Real-Time PCR System (Bio-Rad; Hercules, CA, USA).

The target genes were 100% specific as assessed on 102 bacterial strains since no cross-reactions were observed. The detection limits ranged from 88 colony forming units (CFU)/mL for Enterohemolysin E. coli (EHEC) to 880 CFU/mL Enteropathogenic E. coli (EPEC). Compared with the conventional PCR, the specificity and sensitivity of the multiplex rtPCR was 100% and over 99%, respectively. The coefficient of variation (CV) for each target gene ranged from 0.45% to 1.53%. Of the 171 positive clinical samples, 111 (64.9%) were identified as Enterotoxigenic E. coli (ETEC) and 38 (22.2%) as Enteropathogenic E. coli which were the dominating pathotypes of DEC strains.

The authors concluded that they had developed a rapid and effective two-tube multiplex rtPCR for the identification of all DEC pathotypes. This method took only 90 minutes and saved resources including biochemical reagents, disposable medical supplies and could be used in clinical and public health laboratories. The study was published on July 15, 2014, in the journal Annals of Clinical Microbiology and Antimicrobials.

Related Links:

Xiamen University
Bio-Rad


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Dermatophytosis Rapid Diagnostic Kit
StrongStep Dermatophytosis Diagnostic Kit
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The research team has developed the uCR-Chip device to enhance kidney function testing (Photo courtesy of University of Manitoba)

Low-Cost Portable Screening Test to Transform Kidney Disease Detection

Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.